-+ 0.00%
-+ 0.00%
-+ 0.00%

Sanofi names Paulo Fontoura global head of R&D, replacing Houman Ashrafian

PUBT·06/22/2026 06:00:42
Listen to the news
Sanofi names Paulo Fontoura global head of R&D, replacing Houman Ashrafian
  • Sanofi named Paulo Fontoura executive vice president, global head of R&D Pharma, effective Sept. 1, 2026.
  • Fontoura joins the executive committee in Paris, reporting to CEO Belén Garijo.
  • He replaces Houman Ashrafian, who is leaving to pursue an external role.
  • Fontoura was most recently chief medical officer at Xaira Therapeutics, an AI-focused biotech.
  • He previously spent more than 15 years at Roche, last serving as senior vice president, global head of clinical development across several therapeutic areas.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanofi SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606220200OMX_____CNEWS_EN_GNW1001208833_en) on June 22, 2026, and is solely responsible for the information contained therein.